GYRE THERAPEUTICS, INC. Quarterly Common Stock, Shares, Issued from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Gyre Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q2 2024.
  • Gyre Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 85.5M shares, a 125% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 85.5M +47.6M +125% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 85.4M +47.7M +126% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 76.6M +13M +20.5% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 38M +6.49M +20.6% Sep 30, 2023 10-Q 2023-10-26
Q2 2023 38M +6.5M +20.6% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 37.8M +6.28M +20% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 63.6M +32.2M +102% Dec 31, 2022 10-K 2024-03-27
Q3 2022 31.5M +97.4K +0.31% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 31.5M +127K +0.41% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 31.5M +146K +0.47% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 31.4M +9.31M +42.1% Dec 31, 2021 10-K 2023-03-30
Q3 2021 31.4M +9.31M +42.2% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 31.3M +9.3M +42.2% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 31.3M +13.9M +79.9% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 22.1M +10.1M +83.5% Dec 31, 2020 10-K 2022-03-31
Q3 2020 22.1M +10.1M +83.6% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 22.1M +10M +83.6% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 17.4M +5.45M +45.5% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 12M +86.3K +0.72% Dec 31, 2019 10-K 2021-03-04
Q3 2019 12M +87.3K +0.73% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 12M +65.8K +0.55% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 12M +39K +0.33% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 12M +5.87M +96.6% Dec 31, 2018 10-K 2020-02-20
Q3 2018 11.9M +7.63M +177% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 11.9M +7.63M +177% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 11.9M +10.9M +1093% Mar 31, 2018 10-Q 2018-05-03
Q4 2017 6.08M +5.28M +658% Dec 31, 2017 10-K 2019-03-08
Q3 2017 4.31M -7.63M -63.9% Sep 30, 2017 10-Q 2017-11-02
Q2 2017 4.31M -7.19M -62.5% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 1M -10.4M -91.3% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 802K +39.8K +5.22% Dec 31, 2016 10-K 2018-03-19
Q3 2016 11.9M +524K +4.59% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 11.5M +1.69M +17.3% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 11.4M -22.9M -66.7% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 762K +391K +105% Dec 31, 2015 10-K 2017-03-08
Q3 2015 11.4M -22.4M -66.2% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 9.81M -24M -71% Jun 30, 2015 8-K/A 2015-10-23
Q1 2015 34.3M +526K +1.56% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 371K -9.19M -96.1% Dec 31, 2014 10-K 2016-03-09
Q3 2014 33.8M +135K +0.4% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 33.8M +157K +0.47% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 33.8M +168K +0.5% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 9.56M -24.1M -71.6% Dec 31, 2013 8-K/A 2015-10-23
Q3 2013 33.7M +52.1K +0.16% Sep 30, 2013 10-Q 2013-11-06
Q2 2013 33.6M +208K +0.62% Jun 30, 2013 10-Q 2013-08-07
Q1 2013 33.6M +219K +0.66% Mar 31, 2013 10-Q 2013-05-08
Q4 2012 33.6M +232K +0.69% Dec 31, 2012 10-K 2014-03-14
Q3 2012 33.6M +228K +0.68% Sep 30, 2012 10-Q 2012-11-08
Q2 2012 33.4M +56.6K +0.17% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 33.4M Mar 31, 2012 10-Q 2012-05-09
Q4 2011 33.4M +4.51M +15.6% Dec 31, 2011 10-K 2013-03-15
Q3 2011 33.4M Sep 30, 2011 10-Q 2011-11-03
Q2 2011 33.4M Jun 30, 2011 10-Q 2011-08-09
Q4 2010 28.9M Dec 31, 2010 10-K 2012-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.